Publication | Closed Access
SB203580, a specific inhibitor of p38-MAPK pathway, is a new reversal agent of P-glycoprotein-mediated multidrug resistance
131
Citations
31
References
2001
Year
Drug TargetBiochemistryMedicineReceptor Tyrosine KinaseMechanism Of ActionPharmacotherapyP38-mapk PathwayNew Reversal AgentP-glycoprotein-mediated Multidrug ResistancePharmacologyCell SignalingDrug DiscoveryDrug Resistance
| Year | Citations | |
|---|---|---|
Page 1
Page 1